Center for Cancer and Blood Disorders at Suburban Hospital

Bethesda, Maryland 20817

0 studies enrolling now · 3 studies all time

What they study most

Multiple Myeloma and Plasma Cell Neoplasm, Nausea and Vomiting, Refractory Plasma Cell Neoplasm, Stage II Multiple Myeloma, Stage III Multiple Myeloma, Unspecified Adult Solid Tumor, Protocol Specific

Studies at this site

• APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer — Completed
• Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma — Completed
• Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma — Withdrawn before enrolling